No abstract available
MeSH terms
-
Antiviral Agents / economics
-
Antiviral Agents / therapeutic use*
-
Cost-Benefit Analysis
-
Drug Therapy, Combination
-
Hepatitis C / drug therapy*
-
Hepatitis C / economics
-
Humans
-
Ribavirin / economics
-
Ribavirin / therapeutic use
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Ribavirin